Skip to main content

Table 1 Comparing survival in days for patients with ovarian cancer categorized in different age groups and with high and low KIFC1 expression levels

From: KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries

Age groups (Years)

Survival (days) for high KIFC1 expression

Survival (days) for low KIFC1 expression

30-40

831.7 (N = 11)

1262.2 (N = 12)

40-50

916.2 (N = 57)

1100.2 (N = 54)

50-60

1025.1 (N = 89)

1147.3 (N = 103)

60-70

1239.4 (N = 61)

975.9 (N = 64)